register

News & Trends - Biotechnology

Progressing the long-term plan for stem cell research

Health Industry Hub | October 8, 2019 |

The Morrison Government is pleased to announce the next step in the $150 million Stem Cell Therapies Mission, with the release of the draft Roadmap for public consultation, which will help guide this 10-year investment in medical research. 

The Mission is an opportunity for world-class Australian researchers to further investigate an area which presents significant opportunities for new medical treatments for many chronic and inherited diseases.

Australia is a global leader in stem cell science, with more 300 research laboratories focused on regenerative medicine and cell therapy.

Research advances over the last decade have shown the potential of stem cells to restore function to damaged tissues, engineer replacement tissues and organs and boost the body’s ability to heal itself.

Human stem cells can also be used in the lab to better understand what happens to the body during disease and to test new drugs without any risk to patients.

Fully connected customers are 52% more valuable.
Differentiate your organisation and amplify your brand value proposition to our 8,500+ industry professionals. Health Industry Hub offers a wealth of content in a one-stop-hub to connect and engage Pharma, MedTech and Biotech industry professionals. Ask us how.

The Stem Cell Therapies Mission will support Australia’s talented researchers to further investigate what is possible through stem cell therapies.

The first grant opportunities under the Stem Cell Therapies Mission will begin in the coming months.

A Stem Cell Therapies Expert Advisory Panel has been selected to guide the Mission, and apply its experience and expertise to drafting the Roadmap.

The Morrison Government is funding the mission through its $20 billion Medical Research Future Fund—the single largest boost in health and medical research funding in Australia’s history.

The MRFF supports our world-class Australian researchers to make discoveries, develop a global biotech industry and enable the implementation of significant changes in health care.

For more information on the roadmap, and to provide feedback, visit https://consultations.health.gov.au/health-economics-and-research-division/mrff-stem-cell-therapies-mission

You may also like Multi-cancer blood test expands data in over 20 disease types


News & Trends - Pharmaceuticals

Federal court dismisses Arrotex dispute against Health Minister

Federal court dismisses Arrotex dispute against Health Minister

Health Industry Hub | July 12, 2024 |

Pharma News: The Federal Court has ruled against Arrotex Pharmaceuticals in their bid to challenge the Minister for Health and […]

More


News & Trends - Pharmaceuticals

Largest diabetes study reveals major benefits of dual therapy with SGLT2 inhibitors and GLP1 receptor agonists

Largest diabetes study reveals major benefits of SGLT2 inhibitors and GLP1 receptor agonists dual therapy

Health Industry Hub | July 12, 2024 |

Pharma News: Combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to […]

More


News & Trends - Pharmaceuticals

Queensland opens first regional CAR T-cell treatment centre

Queensland launches first regional CAR T-cell treatment centre

Health Industry Hub | July 12, 2024 |

Pharma News: Gilead Sciences and Lymphoma Australia have welcomed the opening of Australia’s first regional CAR T-cell treatment centre at […]

More


News & Trends - Pharmaceuticals

Government inaction leaves essential medicine shortages unresolved

Government inaction leaves essential medicine shortages unresolved

Health Industry Hub | July 12, 2024 |

Pharma News: Over the past 12 months, at least six essential medications and products have been withdrawn from the Australian […]

More


This content is copyright protected. Please subscribe to gain access.